Anaptysbio (ANAB) Cash from Operations (2016 - 2026)

Anaptysbio has reported Cash from Operations for 11 years, with the latest figure at 25919000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 142.23% year-over-year to 25919000.0; the trailing twelve-month figure through Mar 2026 stood at 4478000.0 (up 104.12% YoY), and the FY2025 full-year result was 19697000.0, up 114.55% from the prior year.
• Cash from Operations for Q1 2026 stood at 25919000.0, down from 97997000.0 in the prior quarter.
• The five-year high for Cash from Operations was 97997000.0 in Q4 2025, with the low at 66672000.0 in Q4 2024.
• Historically, Cash from Operations has averaged 19761882.35 across 5 years, with a median of 24568000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Operations sank 351.77% — and 2025, when it jumped 246.98%.
• Anaptysbio's Cash from Operations stood at 10685000.0 in 2022, then slumped by 221.47% to 34349000.0 in 2023, then sank by 94.1% to 66672000.0 in 2024, then jumped by 246.98% to 97997000.0 in 2025, then tumbled by 126.45% to 25919000.0 in 2026.
• The last three Cash from Operations figures came in at 25919000.0 (Q1 2026), 97997000.0 (Q4 2025), and 27356000.0 (Q3 2025), per Business Quant data.